-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : OPPENHEIMER CUTS TARGET PRICE TO $320 FROM $350

Reuters·10/30/2026 12:12:55

Please log in to view news